Among them, SLC3A2, BRK1, ABI2, ACTR2, NCKAP1, RAC1, RPN1, SLC7A11, and ACTR3 are upregulated in breast cancer, while CYFIP1 and WASF2 were downregulated. Here, SLC3A2 is linked to breast carcinoma.